1)赤芽球癆診療の参照ガイド改訂版作成のためのワーキンググループ.赤芽球癆診療の参照ガイド 令和4年改訂版(第7版).令和5年(2023年)2月.
2)Means RT Jr. Pure red cell aplasia. Blood 2016; 128: 2504-2509.
3)Nakazawa H, et al. Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan. Blood Adv. 2022; 6: 6282-6290.
4)石田文宏.後天性赤芽球癆の臨床的特徴と病態—T細胞異常を中心に.臨血.2022;63:893-898.
5)石田文宏.大顆粒リンパ球増多症.臨検.2017;61:976-982.
6)Kawakami F, et al. T cell clonal expansion and STAT3 mutations: a characteristic feature of acquired chronic T cell-mediated pure red cell aplasia. Int J Hematol. 2022; 115: 816-825.
7)Ishida F, et al. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia. Cancer Sci. 2014; 105: 342-346.
T cells from patients with pure red cell aplasia. Blood Adv. 2018; 2: 2704-2712.
9)Fujishima N, et al. Clonal hematopoiesis in adult pure red cell aplasia. Sci Rep. 2021; 11: 2253.
10)Kawakami T, et al. Somatic mutations in acquired pure red cell aplasia. Semin Hematol. 2022; 59: 131-136.